e-learning
resources
Munich 2014
Monday, 08.09.2014
Cells, biofilms and biomarkers in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Galactomannan in the bronchoalveolar lavage for diagnosing invasive fungal disease
K. Affolter, M. Tamm, K. Jahn, J. Halter, J. Passweg, H. Hirsch, D. Stolz (Basel, Switzerland)
Source:
International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Session:
Cells, biofilms and biomarkers in respiratory infections
Session type:
Thematic Poster Session
Number:
2502
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Affolter, M. Tamm, K. Jahn, J. Halter, J. Passweg, H. Hirsch, D. Stolz (Basel, Switzerland). Galactomannan in the bronchoalveolar lavage for diagnosing invasive fungal disease. Eur Respir J 2014; 44: Suppl. 58, 2502
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
The impact of anti-IgE treatment on the airway microbiome in asthma.
Bronchoalveolar lavage (techniques, indications, results)
Related content which might interest you:
Fungal PCR in the bronchoalveolar lavage for diagnosing invasive fungal disease
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Utility and cost of routine bronchoalveolar lavage in diagnosing pulmonary fungal infections
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Bronchial wash/lavage and etiologic diagnosis on immunocompromised patients
Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy
Year: 2013
Pulmonary nocardiosis-always an opportunist infection?
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: A prospective study in pediatric patients
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Importance of early bronchoalveolar lavage in immunocompromised patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Diagnostic value of galactomannan in bronchoalveolar lavage for invasive pulmonary aspergillosis in immunocompromised children
Source: Annual Congress 2009 - Diagnostic tools in paediatric respiratory infection
Year: 2009
Aspergillus-PCR in bronchoalveolar lavage for detection of invasive fungal disease in immunocompromised patients
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011
Role of bronchoalveolar lavage in new sputum smear negative pulmonary tuberculosis patients
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016
Importance of flexible broncoscopy in immunocompromised children with pulmonary infections
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014
Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Endobronchial biopsies in children with protracted bacterial bronchitis
Source: Annual Congress 2013 –Paediatric bronchology
Year: 2013
Comparison of PCR and culture based detection of pathogens in bronchoalveolar fluid in neutropenic children
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Evaluation of bronchoscopic findings and bronchoalveolar lavage (BAL) fluid cytology with regard to BAL fluid microbiology in critically ill patients.
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Refractory severe asthma: Is presence of aspergillus in broncho-alveolar lavage significant?
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015
Clinical approach to pulmonary sarcoidosis
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016
Bacterial etiology of exacerbations of non-cystic fibrosis bronchiectases in young patients
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013
Diagnostic yield of bronchoalveolar lavage in hematological malignancies
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Clinical and immunological parameters in patients with newly diagnosed sarcoidosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept